Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12233132
Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
granted -
US 12233145
Ultra-violet absorbing compounds
granted -
US 12233105
Methods for storing and warming purified corticotropin compositions
granted -
US 12234263
Influenza vaccines
granted -
US 12233104
Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist
granted -
US 12233119
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
granted -
US 12233086
Biomarkers for neurogenerative disease
granted -
US 12234480
Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells
granted -
US 12233166
Extended release compositions comprising pyridostigmine
granted -
US 12234474
Method to prevent the myelin abnormalites associated with arginase deficiency
granted -
US 12233092
MSC-NTF specific exosomes and use thereof
granted -
US 12234260
Virus-like nanoparticles for oral delivery
granted -
US 12233124
Recombinant metapneumovirus f proteins and their use
granted -
US 12233063
Compositions and methods for treating eye disorders
granted -
US 12233042
Treatment of cutaneous disorders
granted -
US 12234302
Chitosan derivatives and methods for preparing the same
granted -
US 12234288
Immunogenic arginase 2 polypeptides
granted -
US 12234516
Biomarkers of response to HIF-2-alpha inhibition in cancer and methods for the use thereof
granted -
US 12233051
Treating primary or idiopathic hyperoxaluria with small molecule inhibitors of lactate dehydrogenase
granted -
US 12233241
Methods and systems to validate physiologic waveform reliability and uses thereof
granted -
US 12234460
Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
granted -
US 12233090
Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19
granted -
US 12234230
Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof
granted -
US 12234294
Pharmaceutical composition of a humanized anti-CD40 antibody
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.